NO20054976L - Anvendelse av erytropoietin ved rekonvalens eller slag - Google Patents

Anvendelse av erytropoietin ved rekonvalens eller slag

Info

Publication number
NO20054976L
NO20054976L NO20054976A NO20054976A NO20054976L NO 20054976 L NO20054976 L NO 20054976L NO 20054976 A NO20054976 A NO 20054976A NO 20054976 A NO20054976 A NO 20054976A NO 20054976 L NO20054976 L NO 20054976L
Authority
NO
Norway
Prior art keywords
erythropoietin
reconstitution
stroke
epo
invention demonstrates
Prior art date
Application number
NO20054976A
Other languages
English (en)
Norwegian (no)
Inventor
Kenneth Rhodes
Michael Gold
Michael J Renzi
Navneeth Thirumalai
Francis Farrell
Linda Jolliffe
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20054976L publication Critical patent/NO20054976L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
NO20054976A 2003-03-27 2005-10-26 Anvendelse av erytropoietin ved rekonvalens eller slag NO20054976L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45819303P 2003-03-27 2003-03-27
US47749403P 2003-06-11 2003-06-11
PCT/US2004/009443 WO2004087063A2 (en) 2003-03-27 2004-03-26 Use of erythropoietin in stroke recovery

Publications (1)

Publication Number Publication Date
NO20054976L true NO20054976L (no) 2005-10-26

Family

ID=33135092

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054976A NO20054976L (no) 2003-03-27 2005-10-26 Anvendelse av erytropoietin ved rekonvalens eller slag

Country Status (11)

Country Link
US (1) US20040209812A1 (pt)
EP (1) EP1633383A4 (pt)
JP (1) JP2006521405A (pt)
AU (1) AU2004226372A1 (pt)
BR (1) BRPI0408829A (pt)
CA (1) CA2519803A1 (pt)
MX (1) MXPA05010345A (pt)
NO (1) NO20054976L (pt)
NZ (1) NZ542092A (pt)
RU (1) RU2341284C2 (pt)
WO (1) WO2004087063A2 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7345019B1 (en) * 1999-04-13 2008-03-18 The Kenneth S. Warren Institute, Inc. Modulation of excitable tissue function by peripherally administered erythropoietin
US7767643B2 (en) 2000-12-29 2010-08-03 The Kenneth S. Warren Institute, Inc. Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs
US20030072737A1 (en) 2000-12-29 2003-04-17 Michael Brines Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
AU2002325712C1 (en) * 2001-08-30 2008-07-31 Stem Cell Therapeutics Inc. Differentiation of neural stem cells and therapeutic use theeof
CA2460184A1 (en) 2001-09-14 2003-03-27 Stem Cell Therapeutics Inc. Prolactin induced increase in neural stem cell numbers and therapeutical use thereof
US20030054551A1 (en) * 2001-09-18 2003-03-20 Stem Cell Therapeutics Inc. Effect of growth hormone and IGF-1 on neural stem cells
EP1546198A1 (en) * 2002-07-31 2005-06-29 Stem Cell Therapeutics Inc. Method of enhancing neural stem cell proliferation, differentiation, and survival using pituitary adenylate cyclase activating polypeptide (pacap)
AU2004319797A1 (en) * 2003-05-19 2006-01-12 H. Lundbeck A/S Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs with an extended therapeutic window
KR20060013547A (ko) * 2003-05-19 2006-02-10 더 케네쓰 에스. 워렌 인스티튜트 인코포레이티드 확장된 치료 윈도우를 갖는, 반응성 세포, 조직 및 기관의보호, 회복 및 개선을 위한 조직 보호성 사이토카인
ZA200603396B (en) * 2003-09-29 2007-11-28 Warren Pharmaceuticals Inc Tissue protective cytokines for the treatment and prevention of sepsis and the formation of adhesions
WO2005077404A1 (en) 2004-02-13 2005-08-25 Stem Cell Therapeutics Corp. Use of luteinizing hormone (lh) and chorionic gonadotropin (hcg) for proliferation of neural stem cells and neurogenesis
KR20080074108A (ko) 2005-09-27 2008-08-12 스템 셀 테라퓨틱스 코포레이션 프로락틴에 의해 조절되는 올리고덴드로사이트 전구체 세포증식
AU2007229301B2 (en) * 2006-03-17 2013-08-01 Stem Cell Therapeutics Corp. Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents
EP2047859A4 (en) * 2006-06-07 2010-05-05 Univ Tokushima TREATMENT OF ISCHEMIC DISEASE USING ERYTHROPOIETIN
CA2977820A1 (en) * 2008-11-25 2010-06-03 Otsuka Pharmaceutical Co., Ltd. Stem cell for therapeutic use which is derived from human monocyte, and method for inducing same
RU2495688C1 (ru) * 2012-03-28 2013-10-20 Государственное бюджетное учреждение здравоохранения Центр организации специализированной медицинской помощи "Челябинский государственный институт лазерной хирургии" Способ лечения ишемии головного мозга в эксперименте
RU2496513C1 (ru) * 2012-09-27 2013-10-27 Государственное бюджетное учреждение здравоохранения Центр организации специализированной медицинской помощи "Челябинский государственный институт лазерной хирургии" Способ лечения ишемии спинного мозга в эксперименте

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6121246A (en) * 1995-10-20 2000-09-19 St. Elizabeth's Medical Center Of Boston, Inc. Method for treating ischemic tissue
US6165783A (en) * 1997-10-24 2000-12-26 Neuro Spheres Holdings Ltd. Erythropoietin-mediated neurogenesis
DE19857609A1 (de) * 1998-12-14 2000-06-15 Hannelore Ehrenreich Verwendung von Erythropoietin zur Behandlung von cerebralen Ischämien des Menschen
CZ20013695A3 (cs) * 1999-04-13 2002-02-13 Kenneth S. Warren Laboratories Farmaceutický prostředek
US6784154B2 (en) * 2001-11-01 2004-08-31 University Of Utah Research Foundation Method of use of erythropoietin to treat ischemic acute renal failure
KR20060013547A (ko) * 2003-05-19 2006-02-10 더 케네쓰 에스. 워렌 인스티튜트 인코포레이티드 확장된 치료 윈도우를 갖는, 반응성 세포, 조직 및 기관의보호, 회복 및 개선을 위한 조직 보호성 사이토카인

Also Published As

Publication number Publication date
WO2004087063A3 (en) 2005-05-19
EP1633383A4 (en) 2008-05-21
US20040209812A1 (en) 2004-10-21
AU2004226372A1 (en) 2004-10-14
BRPI0408829A (pt) 2006-04-04
WO2004087063A2 (en) 2004-10-14
MXPA05010345A (es) 2006-03-08
RU2341284C2 (ru) 2008-12-20
CA2519803A1 (en) 2004-10-14
EP1633383A2 (en) 2006-03-15
NZ542092A (en) 2008-04-30
JP2006521405A (ja) 2006-09-21
RU2005130023A (ru) 2006-03-20

Similar Documents

Publication Publication Date Title
NO20054976L (no) Anvendelse av erytropoietin ved rekonvalens eller slag
NO20064362L (no) Forbindelser, farmaseutiske sammensetninger og fremgangsmater for anvendelse i behandling av metabolske sykdommer
ECSP088430A (es) Diarilurea para el tratamiento de hipertensión pulmonar
CY1108714T1 (el) Ανταγωνιστες υποδοχεα cgrp
DE60144064D1 (de) Sulfone, die die aktivität von gamma-secretase modulieren
NO20055649L (no) Substituert dihydrokinazolin med antiviale egenskaper
NO20072153L (no) (Bifenyl)-karboksylsyrer og derivater derav
ATE446313T1 (de) Muteine von tränen-lipocalin
DE60224928D1 (de) Dermatologische und kosmetische zusammensetzungen enthaltend ein furfurylderivat
NO20060971L (no) Pyridazinderivater og deres anvendelse som terapeutiske midler
NO20062691L (no) Azabicykliske heterocykler som cannabinoide reseptormodulatorer
NO20064325L (no) Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes
ATE368031T1 (de) Neue gamma secretase inhibitoren
BR0116370A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente.
ATE484505T1 (de) 5-sulfanylmethylä1,2,4ütriazolä1,5-aüpyrimidin- - olderivate als cxcr2-antagonisten
NO20060718L (no) Substituerte tiofoner og deres anvendelse
ATE356606T1 (de) Juckreizstillende kosmetische und dermatologische zubereitungen
ATE398996T1 (de) Haarkonditionierungszusammensetzung
EA200600971A1 (ru) Применение замещённых 2 - аминотетралинов для профилактического лечения болезни паркинсона
NO20076405L (no) Anvendelse av 24-nor-UDCA
NO20001781L (no) 3-amino-3-arylpropan-1-og lignende-derivater, deres fremstilling og anvendelse
NO20075433L (no) Harvann
BR9916807A (pt) Antagonistas de 5ht1 para terapia antidepressiva
ATE423102T1 (de) 4-substituirte-5-cyano-1h-pyrimidin-6-(th)iones als als gsk-3-hemmer
RU2006109966A (ru) Препарат "янтастим-с" для терапии и профилактики инфекционных заболеваний животных

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application